PARODI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 3.830
SA - Sud America 3.454
AS - Asia 3.045
EU - Europa 2.373
AF - Africa 171
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 2
Totale 12.918
Nazione #
US - Stati Uniti d'America 3.713
BR - Brasile 3.167
UA - Ucraina 1.303
CN - Cina 1.196
SG - Singapore 970
DE - Germania 517
HK - Hong Kong 396
IT - Italia 148
TR - Turchia 99
AR - Argentina 89
RU - Federazione Russa 79
FR - Francia 76
FI - Finlandia 70
EC - Ecuador 55
IQ - Iraq 54
MX - Messico 54
SE - Svezia 47
ZA - Sudafrica 47
UZ - Uzbekistan 44
BD - Bangladesh 40
MA - Marocco 38
VE - Venezuela 38
PK - Pakistan 34
GB - Regno Unito 33
CO - Colombia 28
PE - Perù 24
TN - Tunisia 23
AU - Australia 22
AZ - Azerbaigian 22
KR - Corea 22
CA - Canada 21
AT - Austria 18
DZ - Algeria 18
EU - Europa 18
IN - India 18
NP - Nepal 18
OM - Oman 17
UY - Uruguay 17
JO - Giordania 16
KE - Kenya 16
CL - Cile 15
PY - Paraguay 12
BE - Belgio 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
DO - Repubblica Dominicana 9
NL - Olanda 9
PS - Palestinian Territory 9
KG - Kirghizistan 8
SN - Senegal 8
BY - Bielorussia 7
EG - Egitto 7
HN - Honduras 7
IL - Israele 7
LB - Libano 7
PH - Filippine 7
AM - Armenia 6
JM - Giamaica 6
RS - Serbia 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
GT - Guatemala 5
HU - Ungheria 5
JP - Giappone 5
NI - Nicaragua 5
PL - Polonia 5
AL - Albania 4
GE - Georgia 4
LT - Lituania 4
PA - Panama 4
RO - Romania 4
SA - Arabia Saudita 4
BH - Bahrain 3
CH - Svizzera 3
ID - Indonesia 3
IE - Irlanda 3
IR - Iran 3
KW - Kuwait 3
LU - Lussemburgo 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
CY - Cipro 2
ES - Italia 2
GA - Gabon 2
GR - Grecia 2
GS - Georgia del Sud e Isole Sandwich Australi 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NG - Nigeria 2
SY - Repubblica araba siriana 2
TG - Togo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CZ - Repubblica Ceca 1
IS - Islanda 1
Totale 12.910
Città #
Chandler 839
Jacksonville 717
Singapore 598
Dearborn 515
Princeton 410
Hong Kong 393
Nanjing 319
São Paulo 196
Shanghai 158
Wilmington 156
Nanchang 100
Belo Horizonte 96
Rio de Janeiro 92
Shenyang 87
Beijing 80
Helsinki 70
Jiaxing 66
Brasília 61
Tianjin 61
Changsha 58
Curitiba 53
Hebei 53
Santa Clara 51
Porto Alegre 43
Tashkent 42
Salvador 41
Jinan 38
Guarulhos 35
Izmir 33
Ribeirão Preto 33
Campinas 30
Zhengzhou 30
Falkenstein 28
Boardman 27
Norwalk 27
Santo André 27
Baghdad 26
São José dos Campos 26
San Francisco 25
Goiânia 24
Kunming 24
Sassari 23
Taizhou 23
Guayaquil 22
Hangzhou 22
Seoul 22
Sorocaba 22
Ann Arbor 21
Baku 21
Caxias do Sul 21
Contagem 20
Düsseldorf 20
Recife 20
Manaus 19
Uberlândia 19
Johannesburg 18
Florianópolis 17
Istanbul 17
Juiz de Fora 17
Lima 17
Toronto 17
Duque de Caxias 16
Munich 16
Nova Iguaçu 16
São José do Rio Preto 16
Amman 15
Campo Grande 15
Guangzhou 15
Praia Grande 15
Várzea Paulista 15
Ashburn 14
Cape Town 14
Montevideo 14
Nairobi 14
Ningbo 14
Pelotas 14
Fortaleza 13
Frankfurt am Main 13
London 13
Muscat 13
Quito 13
Woodbridge 13
Casablanca 12
Cotia 12
Dhaka 12
Gravataí 12
Joinville 12
Maceió 12
Canoas 11
Changchun 11
Indaiatuba 11
Lahore 11
Lauterbourg 11
Montes Claros 11
Novo Hamburgo 11
Nuremberg 11
Ribeirão das Neves 11
Santiago 11
Sete Lagoas 11
Brussels 10
Totale 6.690
Nome #
Hemoglobin trajectories and blood transfusions associated with percutaneous left atrial appendage occlusion 126
Balloon angioplasty of the radial artery to solve a challenging radial sheath insertion. 91
2017 Update on dual antiplatelet therapy: what's new? 89
Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival. A prospective multicenter randomised trial comparing infarct artery stenting plus abciximab with stenting alone 88
Optimal antiplatelet therapy after an acute coronary syndrome in the elderly: An old issue. 87
Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity. 86
Atrial fibrillation in athletes: from epidemiology to treatment in the novel oral anticoagulants era 86
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry 82
Anxiety trait in patients with stress-induced cardiomyopathy: a case-control study 81
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity. 81
Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study. 81
APpropriateness Assessment in Antiplatelet THerapY (APATHY) registry: Insight from current clinical practice 80
Trying to catch the octopus in the trap: Takotsubo syndrome natural history. 79
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement. 79
Beneficial effects of listening to classical music in patients with heart failure: a randomized controlled trial. 79
[Coronary wire entrapment and unintended extraction of a just deployed stent] 78
Dyspnea related to reversibly-binding P2Y12 inhibitors: A review of the pathophysiology, clinical presentation and diagnostics. 78
Abnormal response to mental stress in patients with Takotsubo cardiomyopathy detected by gated single photon emission computed tomography 78
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19 76
From Risk Factors to Clinical Disease 75
Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation paclitaxel-eluting stents for unprotected left main disease 75
Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry. 75
Chest pain relief in patients with acute myocardial infarction. 75
Sudden floating thrombus formation on the delivery cable before Amplatzer-Amulet device deployment during left atrial appendage occlusion: The need for a standardized anticoagulation. 74
Takotsubo syndrome in Heart Failure and World Congress on Acute Heart Failure 2019: highlights from the experts. 74
Secondary Takotsubo syndrome with severely reduced left ventricular ejection fraction: a warning for clinicians 73
Long-Term Primary Patency Rate After Nitinol Self-Expandable Stents Implantation in Long, Totally Occluded Femoropopliteal (TASC II C & D) Lesions: (Retrospective Study). 72
Anterior mitral leaflet perforation and infective endocarditis following transcatheter aortic valve replacement in a patient presenting with heart failure 72
Impact on Left Ventricular Function and Remodeling and on 1-Year Outcome in Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. 72
Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial 72
Percutaneous Intervention for concurrent chronic total occlusions in patients with STEMI: We should EXPLORE more! 71
Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications 71
Usefulness of the 64-slice multi-detector computed tomography for detecting drug eluting in-stent restenosis 71
Risk Stratification Using the CHA2DS2-VASc Score in Takotsubo Syndrome: Data From the Takotsubo Italian Network. 71
Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic Study. 70
Clinical implication of early mitral regurgitation in patients with reperfused acute myocardial infarction 70
Cardiac abnormalities in Alzheimer Disease. Clinical relevance beyond pathophysiological rationale and instrumental findings? 69
Understanding the complex interplay between coronary artery disease and Takotsubo syndrome: not all swans are white. 69
Relationship between electrocardiographic interatrial blocks and echocardiographic indices of left atrial function in acute heart failure 69
Dyspnoea management in acute coronary syndrome patients treated with ticagrelor. 68
Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. 68
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 68
Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study. 68
Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms 67
Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention 67
. Predictor of Stent Thrombosis in Patients Treated with Turbostratic Carbon-Coated Stent Implantation for Acute Myocardial Infarction 67
Coronary Guidewire Fracture Into a Radial Artery Loop: A New Complication in the Transradial Era? 67
Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathy. 66
Aspirin Adherence in Subjects With glucose-6-phosphate-dehydrogenase Deficiency Having an Acute Coronary Syndrome 66
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty. 66
Effect of diabetes on scintigraphic infarct size in STEMI patients undergoing primary angioplasty. 65
Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. 65
Prognostic value of reverse left ventricular remodeling after primary angioplasty for STEMI 65
Five-year outcome after primary coronary intervention for acute ST elevation myocardial infarction: Results from a single centre experience 65
Significance of additional ST segment elevation in patients with no reflow after angioplasty for acute myocardial infarction 65
Takotsubo is not a cardiomyopathy. 65
Combination of transfemoral balloon-assisted tracking and the knuckle wire technique as a solution in a challenging urgent percutaneous coronary intervention. 65
Mechanical reperfusion in patients with acute myocardial infarction 64
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial 64
Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. 64
Pathophysiology of acute myocardial infarction 64
Takotsubo cardiomyopathy: a consensus document. 64
The short-term prognostic role of chronic kidney disease in Takotsubo syndrome: Does it really matter? 64
Epidemiology of Tako-tsubo cardiomyopathy: the Tuscany Registry for Tako-tsubo Cardiomyopathy 64
The concepts of rescue and facilitated percutaneous interventions in perspective 64
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI 64
Bleeding events and maintenance dose of prasugrel: BLESS pilot study. 64
Long-term prognostic implications of non-optimal primary angioplasty for acute myocardial infarction 63
Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomes 63
Conservative Management and 1-Year Follow-Up of a Huge Left Atrial Intramural Hematoma Related to an Epicardial Collateral Perforation During a Chronic Total Occlusion Percutaneous Coronary Intervention 63
Prognostic relevance of GRACE risk score in Takotsubo syndrome 63
Dual antiplatelet therapy in patients with acute coronary syndrome during coronavirus disease of 2019 pandemia: the right choice at right time. 63
Late coronary stent thrombosis associated with exercise testing. 63
Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. 63
Management of antithrombotic therapy in patients undergoing electrophysiological device surgery. 62
Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from (99m)Tc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention 62
Left ventricular remodeling after primary percutaneous coronary intervention 62
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis) 62
Prevalence, predictors, time course and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction 62
Comparison of AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting With Direct Stenting Alone in Patients With Acute Myocardial Infarction: The JETSTENT Trial 62
High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers. 61
Safety and benefits of protamine administration to revert anticoagulation soon after coronary angioplasty. A meta-analysis 61
Transient left bundle branch block and intraventricular dyssynchrony as a cause of reversibile left ventricular dysfunction. The “in vivo” documentation of spontaneous electrical remodeling. 61
Efficacy and safety of alternative oral administrations of P2Y12-receptor inhibitors: Systematic review and meta-analysis. 61
Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction 60
High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI 60
Tako-tsubo cardiomyopathy and coronary artery disease: a possible association. 60
Distal embolic protection device transit through a left internal mammary artery for safely treating a saphenous vein graft anastomosed at a Y-configuration. 60
Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction 60
Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion 60
Long-term follow-up (4 years) of unprotected left main coronary artery disease treated with paclitaxel eluting stent (from the TRUE Registry) 60
Rheolityc thrombectomy in acute myocardial infarction: Effect on microvascular obstruction, infarct size, and left ventricular remodeling. 59
Comparison of impact of emergency percutaneous revascularization on outcome of patients > 75 years to those < 75 years with acute myocardial infarction complicated by cardiogenic shock 59
Predictors of outcome after sirolimus eluting stent implantation for complex in-stent restenosis 59
Does gender affect the clinical outcome of patients with acute myocardial infarction complicated by cardiogenic shock who undergo percutaneous coronary intervention 59
Randomized comparison of bivalirudin and unfractionated heparin in patients with coronary artery disease undergoing elective percutaneous coronary intervention: The Antithrombotic Regimens aNd Outcome (ARNO) Trial 58
Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomography between subacute and late/very late thrombosis in the Mechanism Of Stent Thrombosis (MOST) study. 58
Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions 58
Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion 58
Dual antiplatelet therapy in elderly patients with acute coronary syndrome: does age make the difference? 58
Totale 6.881
Categoria #
all - tutte 66.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020277 0 0 0 0 0 0 0 0 0 22 221 34
2020/20211.277 201 5 200 2 199 13 199 3 228 212 7 8
2021/2022867 169 4 3 4 2 2 7 70 73 28 94 411
2022/20231.590 219 94 47 278 109 264 0 187 267 6 70 49
2023/2024448 78 28 7 10 48 5 6 7 0 47 71 141
2024/20256.085 21 20 346 82 140 235 270 1.731 2.497 743 0 0
Totale 13.239